๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Liver transplantation and alcohol: Who should get transplants?

โœ Scribed by Ruud A. F. Krom


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
608 KB
Volume
20
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


Medical selection criteria should be the same for all patients with end-stage liver disease and should aim for an acceptable outcome of the liver transplant procedure in matter of survival and quality of life, taking the scarce resources into account. The psychiatric selection criteria should aim at avoidance of recidivism of alcohol use in alcoholic patients. At least 6 mo of sobriety should be required. The patient must have a stable and supportive environment and should participate in an alcohol counseling program. A multicentered trial using uniform scoring criteria such as the Alcohol Prognosis Scale is needed to better define the selection of patients with alcoholic liver disease and long-term outcome of alcoholism after transplantation. (HEPATOLOGY 1994;20:28S-328.)

Liver transplantation was recognized as a modality of treatment for end-stage liver disease during the National Institutes of Health Consensus Conference in 1983, and its potential for end-stage cholestatic, parenchymal and metabolic liver disease was defined (1). In that context a short paragraph was devoted to alcoholrelated liver disease. Although it was recognized that alcohol-related liver disease is the most common form of fatal liver disease in America, the assumption was also made that only a small proportion of alcoholic patients would meet the rigorous criteria for liver transplantation. These rigorous criteria were related to the medical condition of the patient as well as to alcoholism. Specifically, the patient's abstinence from alcohol was stated as one of the criteria. Five years later, Starzl (2) published the first paper on the results of liver transplantation in alcoholic patients. He demonstrated that the survival of patients with end-stage alcoholic liver disease was equal to that of patients with end-stage liver disease from other causes. Since then the percentage of patients receiving liver transplants for end-stage alcoholic liver disease has increased to 22% of all transplants performed in 1992. In 1990 36,000 patients died from alcoholic liver disease in the United States. The 600 patients who received liver transplants in 1992 are


๐Ÿ“œ SIMILAR VOLUMES


HCC - Who should we transplant?
โœ Vicenzo Mazzaferro ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 26 KB
Who should receive the liver allograft:
โœ Klintmalm, Goran B. ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 400 KB

Welchel JD. For the UNOS Ad Hoc Allocation Committee. Background: problems and concerns in equitable organ allocation. Appendix D to the UNOS Statement of Principles and Objectives of Equitable Organ Allocation. Richmond: UNOS, 1994:26-43. Welchel JD. For the UNOS Ad Hoc Allocation Committee. Backgr

Should we perform deceased donor liver t
โœ Paul D. Greig; Andreas Geier; Anthony M. D'Alessandro; Michael Campbell; Linda W ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 111 KB ๐Ÿ‘ 1 views

By asking whether we should perform deceased donor liver transplantation (DDLT) after living donor liver transplantation (LDLT) has failed, we appear to be questioning the generally accepted current practice of retransplantation for transplant failure. However, we will also consider in this analysis

Orthotopic liver transplantation for alc
โœ Shashi Kumar; Rudolf E. Stauber; Judith S. Gavaler; Michael H. Basista; Vincents ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 487 KB

Alcohol abuse is the most common cause of end-stage liver disease in the United States, but many transplant centers are unwilling to accept alcoholic patients because of their supposed potential for recidivism, poor compliance with the required immunosuppression regimen and resulting failure of the

Liver transplantation for porphyria: Who
โœ Avnish Kumar Seth; Michael N. Badminton; Darius Mirza; Scott Russell; Elwyn Elia ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 176 KB

Porphyrias are a heterogenous group of diseases that may result in disabling or life threatening neurovisceral symptoms and/or cutaneous photosensitivity. In acute intermittent porphyria, the clinical features, particularly neurological symptoms, may be life-threatening and disabling. Conventional t